Source and scope
This summary is bounded to the recommendations, population and decisions covered by Human Immunodeficiency Virus — HIV Screening and Testing Guide. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:PHAC HIV testing
Source-attributed clinical priorities
- Offer HIV testing through informed consent and a non-stigmatizing risk and prevention discussion.
- Use a fourth-generation laboratory test or the approved local rapid-testing algorithm and recognize the window period.
- Arrange urgent confirmatory testing and linkage to HIV care for a reactive result, while addressing partner and public-health requirements.
- Offer HIV testing with consent whenever the result will inform care, without requiring disclosure of a particular risk identity.
sources for this section:PHAC HIV testing
Practical assessment and management workflow
1
Explain the test and confidentiality and identify timing of the last possible exposure.
2
Use a laboratory antigen-antibody or appropriate point-of-care pathway and understand its window period.
3
Arrange supplemental testing and rapid linkage after a reactive result.
4
Repeat testing after a recent exposure when the initial result may fall within the window period.
sources for this section:PHAC HIV testing
Safety, red flags and urgent escalation
- Do not delay post-exposure prophylaxis while waiting for a test result.
- Symptoms compatible with acute HIV after a recent exposure require antigen-antibody and nucleic-acid assessment.
- Communicate results through a reliable confidential process and follow provincial reporting rules.
sources for this section:PHAC HIV testing
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:PHAC HIV testing
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:PHAC HIV testing
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Public Health Agency of CanadaHuman Immunodeficiency Virus — HIV Screening and Testing Guideaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.